I think I did mention nothing happening soon .... LOL ..... but of course I'm not the CEO. My opinion is Dahl had the company on a course to nowhere cause he had no knowledge of the pharma/biotech/agtech anything .... and no interpersonal skills either as a leader or influencer. And unfortunately for investors was allowed to hand on far too long.
Anyway .... as noted .... I'll be looking for bottom for the next swing position.
I also believe they're ok on cash til year end ... the raise situation could be influenced by the results of the poultry testing and a potential license situation and the timing therof. But if it goes out into next year, need money plain and simple.
Nice letter though. Somewhat what I would have expected with the shareholder meeting as previously stated here.
Market Data 
Markets 
